ABT Stock Recent News
ABT LATEST HEADLINES
Johnson & Johnson and Abbott Laboratories have impressive track records of paying and growing their dividends. Both healthcare leaders have robust businesses and exciting growth opportunities.
Inflation came in much hotter than expected in February. Core services inflation, which excludes housing, rose 0.5% from January following a 0.9% increase from December.
As the world economy teeters on the verge of instability, three titans have survived many financial storms and emerged stronger than ever from the waves of uncertainty. Here, recognizing these business titans' strategic acumen reveals a means to protect riches.
Abbott (ABT) closed at $111.50 in the latest trading session, marking a -1.47% move from the prior day.
In the most recent trading session, Abbott (ABT) closed at $113.16, indicating a +0.64% shift from the previous trading day.
Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.